Syringe treated with transdermal venous access locking solutions and method of treating the syringe
US9427498B2 · kind B2 · utility
Inventors
Key dates
| Filing date | Apr 28, 2015 |
| Grant date | Aug 30, 2016 |
| Priority date | — |
| Expiry date | May 22, 2035 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61M2039/0258
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Microbial growth inhibiting solutions and methods of employing the microbial growth inhibiting solutions in flushing and coating medical devices are disclosed. In alternative embodiments, the microbial growth inhibiting solutions include combinations of a chelating agent with a C4-C12 carboxylate antimicrobial agent, for example, such as n-capric, n-lauric, or n-octanoic acid. Methods of using these microbial growth inhibiting solutions for coating a medical device and for inhibiting catheter infection are also disclosed. Methods of using these microbial growth inhibiting solutions, or portions thereof, as leaching treatment solutions to treat polymer syringes and the treated syringes are also disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.